Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
My Heart Lab
2022

Share:

My Heart Lab

Medical research study

SAMSUNG Samsung Research America

AFib is an irregular heart rhythm typically affecting people 65+ that can lead to serious complications. The CDC estimates that 12 million people in the US will have AFib by 2030. My Heart Lab is a research study app that allows users to detect and monitor possible AFib and share comprehensive reports with their doctors — enabling users and doctors to monitor heart rhythms actively and passively. My Heart Lab’s complete ecosystem of phone watch apps plus clinician reports includes the world’s first watch app to combine PPG technology for continuous AFib monitoring with a verification ECG and the world’s first to feature AFib burden assessment.

Date of Launch
2020
Development Time
up to 12 months
Target Regions
North America
Target Groups
Consumer / User, Other target groups: AFib Research Participants

RELATED PROJECTS